Shell Asset Management CO Aurinia Pharmaceuticals Inc. Transaction History

Shell Asset Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$10.93 - $23.55 $4,481 - $9,655	-410 Reduced 3.95%	9,965 $132,000
Q1 2021 May 10, 2021	BUY	$12.3 - $18.73 $2,681 - $4,083	218 Added 2.15%	10,375 $135,000
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $109,938 - $136,360	8,496 Added 511.5%	10,157 $140,000
Q3 2020 Nov 13, 2020	BUY	$13.19 - $16.66 $6,806 - $8,596	516 Added 45.07%	1,661 $24,000
Q2 2020 Aug 10, 2020	SELL	$14.12 - $18.33 $23,368 - $30,336	-1,655 Reduced 59.11%	1,145 $19,000
Q4 2019 Feb 13, 2020	SELL	$3.88 - $21.42 $8,761 - $48,366	-2,258 Reduced 44.64%	2,800 $57,000
Q2 2019 Aug 12, 2019	SELL	$6.05 - $6.75 $859 - $958	-142 Reduced 2.73%	5,058 $33,000
Q1 2018 May 14, 2018	BUY	$4.85 - $5.99 $5,335 - $6,589	1,100 Added 26.83%	5,200 $27,000
Q4 2017 Feb 09, 2018	BUY	$4.53 - $7.09 $18,573 - $29,069	4,100	4,100 $19,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.